VDR and head and neck squamous cell carcinoma: Consistent with our findings, previous research has demonstrated that VDR is expressed in head and neck squamous cell carcinoma (HNSCC) tumors, and that adding 1,25(OH)2D3 to chemotherapy can reduce tumor growth and cell migration [99].